(Q45423889)

14 December 2017

title

Screening to prevent polyoma virus nephropathy: a medical decision analysis (English)

1 reference

14 December 2017

1 reference

1 reference

Bryce A Kiberd

1

1 reference

14 December 2017

language of work or name

English

0 references

publication date

1 October 2005

1 reference

American Journal of Transplantation

14 December 2017

published in

1 reference

14 December 2017

volume

5

1 reference

14 December 2017

issue

10

1 reference

14 December 2017

page(s)

2410-2416

1 reference

Polyomavirus nephropathy: what have we learned?

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01034.X

BK virus nephropathy--polyomavirus adding insult to injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01034.X

New human papovavirus (B.K.) isolated from urine after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01034.X

Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01034.X

Human Polyomavirus Infections with JC Virus and BK Virus in Renal Transplant Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01034.X

Clinical course of polyoma virus nephropathy in 67 renal transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01034.X

Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01034.X

Polyomavirus Allograft Nephropathy: Sequential Assessment of Histologic Viral Load, Tubulitis, and Graft Function Following Changes in Immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01034.X

Quantitative viral load monitoring and cidofovir therapy for the management of BK virus-associated nephropathy in children and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01034.X

Human polyoma virus-associated interstitial nephritis in the allograft kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01034.X

Immunosuppression: practice and trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01034.X

Mycophenolate mofetil dose reduction and the risk of acute rejection after renal transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01034.X

The impact of mycophenolate mofetil dosing patterns on clinical outcome after renal transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01034.X

Minimization of immunosuppressive therapy after renal transplantation: results of a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01034.X

Cyclosporine microemulsion and tacrolimus are associated with decreased chronic allograft failure and improved long-term graft survival as compared with sandimmune

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01034.X

Mycophenolate mofetil versus azathioprine therapy is associated with a significant protection against long-term renal allograft function deterioration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01034.X

Cost-effectiveness of extending Medicare coverage of immunosuppressive medications to the life of a kidney transplant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01034.X

The expanded criteria donor dilemma in cadaveric renal transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01034.X

Economic analysis of basiliximab in renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01034.X

Standards for economic and quality of life studies in transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01034.X

Prevalence of BK virus and JC virus in peripheral blood leukocytes and normal arterial walls in healthy individuals in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01034.X

Leflunomide for polyomavirus type BK nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01034.X

Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01034.X

BK virus-associated nephropathy in renal allograft recipients: rescue therapy by sirolimus-based immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01034.X

Predicting kidney graft failure by HLA antibodies: a prospective trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01034.X

10.1111/J.1600-6143.2005.01034.X

21 January 2018

Identifiers

DOI

1 reference

14 December 2017

1 reference